This company stands to benefit from a shifting pharmaceutical industry landscape. As a biotech that's leaning heavily on artificial intelligence (AI) in every aspect of its business, Recursion Pharmaceuticals (RXRX 1.89%) is hooked into a handful of big trends that will likely define the future of its industry. There isn't any guarantee that the company will be a good investment on the force or direction of those trends alone. But there are three which are especially bullish for the stock thanks to how it's ...